| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |